Nicola Mason, BVetMed, PhD, of Penn Vet was featured on CBS' 60 Minutes, where she spoke about her research on immunotherapy treatment for cancer in dogs.
Scout Bio, a Philadelphia company developing gene therapies for animal health, has licensed a new kind of technology from the Penn’s gene therapy program.
In experiments using saliva samples from COVID-19 patients, the gum, which contains the ACE2 protein, neutralized the virus, according to research led by School of Dental Medicine scientists.
The event honors the patent recipients from the previous fiscal year, as well as, those partners, inventors, and startups that made exceptional achievements.
The company has now raised more than $35 million since its inception.
Webinar hosted by the Penn Center for Innovation with Dr. Kathryn Doyle, Partner, Saul Ewing Arnstein & Lehr.
A newly developed single-cell RNA sequencing technique enables researchers to quickly identify an optimal vector for delivering therapeutic genetic material to treat vision disorders.
Iveric Bio entered into a sponsored research agreement with Drs. Karina Guziewicz and William Beltran both from the School of Veterinary Medicine.
As part of Philly Tech Week 2021 and the Technical.ly Philly Introduced Conference, PCI and the Pennovation Center, hosted an educational webinar on the range of innovations emerging from Penn in the